Parathyroid hormone inhibits c-Jun N-terminal kinase activity in rat osteoblastic cells by a protein kinase

Teresa A Doggett1, John T Swarthout, Stephen C Jefcoat

  • 1Cell and Molecular Biology Program, Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.

Endocrinology
|April 17, 2002
PubMed

Insights

Parathyroid hormone (PTH) treatment inhibits c-Jun-NH(2)-terminal kinase (JNK) activity in osteoblastic cells. This inhibition occurs via the protein kinase A (PKA) signaling pathway, affecting upstream JNK cascade members.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Endocrinology

Background:

  • Parathyroid hormone (PTH) activates dual signaling cascades, protein kinase A (PKA) and protein kinase C (PKC), in osteoblastic cells.
  • PTH's effect on extracellular signal-regulated kinases (ERKs) is dose-dependent, but its regulation of other mitogen-activated protein kinase (MAPK) family members, like c-Jun-NH(2)-terminal kinase (JNK), remains unclear.
  • JNK is typically activated by cellular stress and cytokines, playing a crucial role in transcription factor regulation.

Purpose of the Study:

  • To investigate the effect of PTH on JNK activity in osteoblastic cells.
  • To determine if PTH regulates other members of the MAPK family, specifically JNK.
  • To elucidate the signaling pathway through which PTH influences JNK activity.

Main Methods:

  • Treatment of UMR 106-01 cells and rat calvarial osteoblasts with PTH (10(-8) M).
  • Treatment with N-terminal PTH peptides selective for PKA activation.
  • Treatment with 8-bromo-cAMP to activate PKA.
  • Assay of JNK activity and upstream components of the JNK cascade, including stress-activated protein kinase/extracellular signal-related kinase kinase 1/MAPK kinase 4 and MAPK/extracellular signal-related kinase kinase kinase 1.

Main Results:

  • PTH treatment significantly inhibited high basal JNK activity in osteoblastic cells.
  • N-terminal PTH peptides and 8-bromo-cAMP also resulted in the inhibition of JNK activity.
  • PTH treatment led to the inhibition of upstream signaling components of the JNK cascade, specifically SAPK/ERK kinase 1 and MAPK/ERK kinase 1.

Conclusions:

  • PTH inhibits high basal JNK activity in osteoblastic cells.
  • The PKA signaling cascade is responsible for PTH-mediated inhibition of JNK.
  • PTH influences the JNK pathway through its upstream activators via PKA activation.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...